BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17641901)

  • 1. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma.
    Brunn A; Montesinos-Rongen M; Strack A; Reifenberger G; Mawrin C; Schaller C; Deckert M
    Acta Neuropathol; 2007 Sep; 114(3):271-6. PubMed ID: 17641901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma.
    Fujii A; Ohshima K; Hamasaki M; Makimoto Y; Haraoka S; Utsunomiya H; Okazaki M; Kikuchi M
    Int J Oncol; 2004 Mar; 24(3):529-38. PubMed ID: 14767537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1.
    Smith JR; Falkenhagen KM; Coupland SE; Chipps TJ; Rosenbaum JT; Braziel RM
    Am J Clin Pathol; 2007 Apr; 127(4):633-41. PubMed ID: 17369141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
    Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
    J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
    Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
    Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma.
    Smith JR; Braziel RM; Paoletti S; Lipp M; Uguccioni M; Rosenbaum JT
    Blood; 2003 Feb; 101(3):815-21. PubMed ID: 12393412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
    Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation.
    Maru SV; Holloway KA; Flynn G; Lancashire CL; Loughlin AJ; Male DK; Romero IA
    J Neuroimmunol; 2008 Aug; 199(1-2):35-45. PubMed ID: 18538864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL13 and CXCL12 in central nervous system lymphoma patients.
    Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
    Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.
    Deutsch AJ; Aigelsreiter A; Steinbauer E; Frühwirth M; Kerl H; Beham-Schmid C; Schaider H; Neumeister P
    J Pathol; 2008 Aug; 215(4):431-44. PubMed ID: 18561120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro.
    Brenier-Pinchart MP; Blanc-Gonnet E; Marche PN; Berger F; Durand F; Ambroise-Thomas P; Pelloux H
    Acta Neuropathol; 2004 Mar; 107(3):245-9. PubMed ID: 14722715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant increase in the expression of matrix metalloproteinase 7 in primary CNS lymphoma.
    Matsumoto T; Kumagai J; Hasegawa M; Tamaki M; Aoyagi M; Ohno K; Mizusawa H; Kitagawa M; Eishi Y; Koike M
    Neuropathology; 2008 Jun; 28(3):277-85. PubMed ID: 18179407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [mRNA expression of chemokine receptors in hepatic and pancreatic tumor cell lines].
    Masai K; Iwashita Y; Tominaga M; Hirano S; Shibata K; Matsumoto T; Sasaki A; Ohta M; Kitano S
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1261-3. PubMed ID: 15332556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas.
    D'Haene N; Catteau X; Maris C; Martin B; Salmon I; Decaestecker C
    Br J Haematol; 2008 Feb; 140(4):402-10. PubMed ID: 18081894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.
    Cepok S; Schreiber H; Hoffmann S; Zhou D; Neuhaus O; von Geldern G; Hochgesand S; Nessler S; Rothhammer V; Lang M; Hartung HP; Hemmer B
    Arch Neurol; 2009 Oct; 66(10):1216-23. PubMed ID: 19667211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CXC chemokines and their receptors is modulated during chondrogenic differentiation of human mesenchymal stem cells grown in three-dimensional scaffold: evidence in native cartilage.
    Cristino S; Piacentini A; Manferdini C; Codeluppi K; Grassi F; Facchini A; Lisignoli G
    Tissue Eng Part A; 2008 Jan; 14(1):97-105. PubMed ID: 18333808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aquaporin-4 expression in primary human central nervous system lymphomas correlates with tumour cell proliferation and phenotypic heterogeneity of the vessel wall.
    Nico B; Annese T; Tamma R; Longo V; Ruggieri S; Senetta R; Cassoni P; Specchia G; Vacca A; Ribatti D
    Eur J Cancer; 2012 Mar; 48(5):772-81. PubMed ID: 22100902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13.
    Stich S; Loch A; Leinhase I; Neumann K; Kaps C; Sittinger M; Ringe J
    Eur J Cell Biol; 2008 Jun; 87(6):365-76. PubMed ID: 18501472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization.
    Han JI; Huang NN; Kim DU; Kehrl JH
    J Leukoc Biol; 2006 Jun; 79(6):1357-68. PubMed ID: 16565322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.